PubMed · 2013 · 14 citations · 27 references
MedicineOncologyPathologyHistopathologyNeoplasiaTumor PathologyHepatocellular CarcinomaImmunohistochemistryLiver CancerTumor AntigensTumor MarkersTumor-associated AntigensAntibodiesCancer AntigensCancer/testis Antigen ExpressionCorrelationImmunohistochemical StainingMarker Expression PatternsTumor Grade AssessmentTumor Grade Classification
UNLABELLED: This study is dedicated to investigate the expression patterns of sperm protein 17 (Sp17), melanoma-specific antigen (MAGE)-C1 and New York esophageal squamous cell carcinoma-1 (NY-ESO-1), to explore the correlation between these cancer-testis antigens and clinical parameters, and to evaluate their values in diagnosis and differentiation of hepatocellular carcinoma. METHODS: Immunohistochemical staining was performed in 45 paraffin-embedded hepatocellular carcinoma specimens. 45 normal peripheral hepatic tissues collected from adjacent non-cancerous areas were used as controls. RESULTS: Positive results of immunohistostaining were obtained in 16 (35.6%), 7 (15.6%) and 36 (80.0%) samples using MAGE-C1, NY-ESO-1 and Sp17 antibodies, respectively. The immunoreactivity of Sp17 was also found in 7 (14.0%) control samples. A statistical correlation between the frequency of Sp17 expression and tumor differentiation grade in hepatocellular carcinoma was confirmed. CONCLUSIONS: Sp17 is highly expressed in hepatocellular carcinoma cells. The frequency of Sp17 expression is closely related to the pathologic differentiation in hepatocellular carcinoma.
27
Rebecca L. Siegel, Elizabeth Ward, Otis W. Brawley et al. · CA A Cancer Journal for Clinicians · 2011 · 4.1K citations · Full text
Hepatocellular carcinoma. An overview
Daniel Motola‐Kuba, Daniel Zamora‐Valdés, Misael Uribe et al. · Annals of Hepatology · 2006 · 176 citations · Full text